<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38684843</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Cognitive profile in multiple sclerosis and post-COVID condition: a comparative study using a unified taxonomy.</ArticleTitle><Pagination><StartPage>9806</StartPage><MedlinePgn>9806</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9806</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-60368-0</ELocationID><Abstract><AbstractText>Post-COVID condition (PCC) and multiple sclerosis (MS) share some clinical and demographic features, including cognitive symptoms and fatigue. Some pathophysiological mechanisms well-known in MS, such as autoimmunity, neuroinflammation and myelin damage, have also been implicated in PCC. In this study, we aimed to compare the cognitive phenotypes of two large cohorts of patients with PCC and MS, and to evaluate the relationship between fatigue and cognitive performance. Cross-sectional study including 218 patients with PCC and 218 with MS matched by age, sex, and years of education. Patients were evaluated with a comprehensive neuropsychological protocol and were categorized according to the International Classification of Cognitive Disorders system. Fatigue and depression were also assessed. Cognitive profiles of PCC and MS largely overlapped, with a greater impairment in episodic memory in MS, but with small effect sizes. The most salient deficits in both disorders were in attention and processing speed. The severity of fatigue was greater in patients with PCC. Still, the correlations between fatigue severity and neuropsychological tests were more prominent in the case of MS. There were no differences in the severity of depression among groups. Our study found similar cognitive profiles in PCC and MS. Fatigue was more severe in PCC, but was more associated with cognitive performance in MS. Further comparative studies addressing the mechanisms related to cognitive dysfunction and fatigue may be of interest to advance the knowledge of these disorders and develop new therapies.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Delgado-Alonso</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Alvarez</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;ez-Cirarda</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliver-Mas</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuevas</LastName><ForeName>Constanza</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero-Escribano</LastName><ForeName>Paloma</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Lev&#xed;</LastName><ForeName>Ana Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Moreno</LastName><ForeName>Mar&#xed;a Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Carbonero</LastName><ForeName>Juan Ignacio</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Bruce P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matias-Guiu</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matias-Guiu</LastName><ForeName>Jordi A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5520-2708</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Instituto de Investigacion Sanitaria "San Carlos" (IdISSC), C/Profesor Mart&#xed;n Lagos, 28040, Madrid, Spain. jordimatiasguiu@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>INT20/00079</GrantID><Agency>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</Agency><Country/></Grant><Grant><GrantID>INT23/00017</GrantID><Agency>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</Agency><Country/></Grant><Grant><GrantID>CD22/00043</GrantID><Agency>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="Y">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="Y">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Multiple sclerosis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>29</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38684843</ArticleId><ArticleId IdType="pmc">PMC11059260</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-60368-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-60368-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertuccelli M, et al. Cognitive impairment in people with previous COVID-19 infection: A scoping review. Cortex. 2022;154:212&#x2013;230. doi: 10.1016/j.cortex.2022.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9187867</ArticleId><ArticleId IdType="pubmed">35780756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Brain behavior and immunity fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, et al. Post-acute sequelae of covid-19 six to 12 months after infection: Population based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:611. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroli A, et al. Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations. NeuroImage Clin. 2023;37:103338. doi: 10.1016/j.nicl.2023.103338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2023.103338</ArticleId><ArticleId IdType="pmc">PMC9883079</ArticleId><ArticleId IdType="pubmed">36731251</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M, et al. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. 2023;146:2142&#x2013;2152. doi: 10.1093/brain/awac384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac384</ArticleId><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, et al. Cerebral micro-structural changes in COVID-19 patients&#x2013;an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajcevic M, et al. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci. Rep. 2023;13:5808. doi: 10.1038/s41598-023-32275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32275-3</ArticleId><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="pubmed">37037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolini M, et al. Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study. Eur. Neuropsychopharmacol. 2023;68:1&#x2013;10. doi: 10.1016/j.euroneuro.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9742225</ArticleId><ArticleId IdType="pubmed">36640728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Toniolo S, Hampshire A, Husain M. Effects of COVID-19 on cognition and brain health. Trends Cognit. Sci. 2023;27:1053&#x2013;1067. doi: 10.1016/j.tics.2023.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2023.08.008</ArticleId><ArticleId IdType="pmc">PMC10789620</ArticleId><ArticleId IdType="pubmed">37657964</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022 doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine J, et al. Articles structural brain changes in patients with post-COVID fatigue: A prospective observational study. eClinicalMedicine. 2023;58:101874. doi: 10.1016/j.eclinm.2023.101874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101874</ArticleId><ArticleId IdType="pmc">PMC9969172</ArticleId><ArticleId IdType="pubmed">36873426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#xed;as-Guiu JA, et al. Identification of cortical and subcortical correlates of cognitive performance in multiple sclerosis using voxel-based morphometry. Front. Neurol. 2018;9:1&#x2013;12. doi: 10.3389/fneur.2018.00920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00920</ArticleId><ArticleId IdType="pmc">PMC6216547</ArticleId><ArticleId IdType="pubmed">30420834</ArticleId></ArticleIdList></Reference><Reference><Citation>Petracca M, et al. Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis. Brain Sci. 2021;11:346. doi: 10.3390/brainsci11030346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030346</ArticleId><ArticleId IdType="pmc">PMC8000635</ArticleId><ArticleId IdType="pubmed">33803287</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda, A. et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. BioRxiv (2022).</Citation></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long covid prevalence and its relationship to epstein-barr virus reactivation. Pathogens. 2021;10:1&#x2013;15. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisi F, Giovannoni G, Salvetti M. Epstein&#x2013;Barr virus as a cause of multiple sclerosis: Opportunities for prevention and therapy. Lancet. Neurol. 2023;22:338&#x2013;349. doi: 10.1016/S1474-4422(22)00471-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00471-9</ArticleId><ArticleId IdType="pubmed">36764322</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, et al. Association of Post-COVID-19 condition symptoms and employment status. JAMA Netw. Open. 2023;6:e2256152. doi: 10.1001/jamanetworkopen.2022.56152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.56152</ArticleId><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanken K, Eling P, Hildebrandt H. Is there a cognitive signature for MS-related fatigue? Multiple Scler. 2015;21:376&#x2013;381. doi: 10.1177/1352458514549567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458514549567</ArticleId><ArticleId IdType="pubmed">25257615</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria M, et al. Post-COVID-19 fatigue: The contribution of cognitive and neuropsychiatric symptoms. J. Neurol. 2022;269:3990&#x2013;3999. doi: 10.1007/s00415-022-11141-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11141-8</ArticleId><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu JA, et al. Neuropsychological predictors of fatigue in Post-COVID syndrome. J. Clin. Med. 2022;11:1&#x2013;13. doi: 10.3390/jcm11133886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133886</ArticleId><ArticleId IdType="pmc">PMC9267301</ArticleId><ArticleId IdType="pubmed">35807173</ArticleId></ArticleIdList></Reference><Reference><Citation>Leavitt VM, et al. Dissociable cognitive patterns related to depression and anxiety in multiple sclerosis. Multiple Scler. 2020;26:1247&#x2013;1255. doi: 10.1177/1352458519860319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458519860319</ArticleId><ArticleId IdType="pmc">PMC6928451</ArticleId><ArticleId IdType="pubmed">31233379</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, et al. Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. Eur. J. Neurol. 2023 doi: 10.1111/ene.16084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.16084</ArticleId><ArticleId IdType="pubmed">37797297</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J. Psychiatr. Res. 2022;150:40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Mat&#xed;as-Guiu JA, et al. Validation of the Neuronorma battery for neuropsychological assessment in multiple sclerosis. Multiple Scler. Relat. Disord. 2020;42:102070. doi: 10.1016/j.msard.2020.102070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102070</ArticleId><ArticleId IdType="pubmed">32330845</ArticleId></ArticleIdList></Reference><Reference><Citation>Polman CH, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011;69:292&#x2013;302. doi: 10.1002/ana.22366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22366</ArticleId><ArticleId IdType="pmc">PMC3084507</ArticleId><ArticleId IdType="pubmed">21387374</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, et al. Spanish multicenter normative studies (NEURONORMA project): Methods and sample characteristics. Arch. Clin. Neuropsychol. 2009;24:307&#x2013;319. doi: 10.1093/arclin/acp027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acp027</ArticleId><ArticleId IdType="pubmed">19549723</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, et al. Estudios normativos espa&#xf1;oles en poblaci&#xf3;n adulta joven (Proyecto NEURONORMA j&#xf3;venes): M&#xe9;todos y caracter&#xed;sticas de la muestra. Neurologia. 2012;27:253&#x2013;260. doi: 10.1016/j.nrl.2011.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2011.12.019</ArticleId><ArticleId IdType="pubmed">22397892</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Benavides G, et al. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer&#x2019;s disease: Data from the Spanish Multicenter Normative Studies (NEURONORMA Project) J. Alzheimer&#x2019;s Dis. 2014;41:887&#x2013;901. doi: 10.3233/JAD-132186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-132186</ArticleId><ArticleId IdType="pubmed">24718100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kos D, et al. Evaluation of the modified fatigue impact scale in four different European countries. Multiple Scler. 2005;11:76&#x2013;80. doi: 10.1191/1352458505ms1117oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1352458505ms1117oa</ArticleId><ArticleId IdType="pubmed">15732270</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck, A. T. Manual for the beck depression inventory-II. (No Title) (1996).</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. (2022).</Citation></Reference><Reference><Citation>Hancock LM, et al. A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS) Multiple Scler. J. 2022;29:615&#x2013;627. doi: 10.1177/13524585221127941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13524585221127941</ArticleId><ArticleId IdType="pubmed">36239099</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu JA, et al. Development of criteria for cognitive dysfunction in post-COVID syndrome: The IC-CoDi-COVID approach. Psychiatry Res. 2023;319:115006. doi: 10.1016/j.psychres.2022.115006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.115006</ArticleId><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman M, et al. Addressing neuropsychological diagnostics in adults with epilepsy: Introducing the International Classification of Cognitive Disorders in Epilepsy: The IC CODE Initiative. Epilepsia Open. 2021;6:266&#x2013;275. doi: 10.1002/epi4.12478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/epi4.12478</ArticleId><ArticleId IdType="pmc">PMC8166800</ArticleId><ArticleId IdType="pubmed">34033259</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald CR, et al. Development and application of the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE): Initial results from a multi-center study of adults with temporal lobe epilepsy. Neuropsychology. 2022;37:301&#x2013;314. doi: 10.1037/neu0000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/neu0000792</ArticleId><ArticleId IdType="pmc">PMC9325925</ArticleId><ArticleId IdType="pubmed">35084879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Fernandez E, Huang J. Cognitive aspects of COVID-19. Curr. Neurol. Neurosci. Rep. 2023;23:531&#x2013;538. doi: 10.1007/s11910-023-01286-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-023-01286-y</ArticleId><ArticleId IdType="pubmed">37490194</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol. 2020;19:860&#x2013;871. doi: 10.1016/S1474-4422(20)30277-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30277-5</ArticleId><ArticleId IdType="pmc">PMC10011205</ArticleId><ArticleId IdType="pubmed">32949546</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-&#xc1;lvarez A, et al. Cognitive processes underlying verbal fluency in multiple sclerosis. Front. Neurol. 2021;11:1&#x2013;11. doi: 10.3389/fneur.2020.629183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.629183</ArticleId><ArticleId IdType="pmc">PMC7859643</ArticleId><ArticleId IdType="pubmed">33551984</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes A, et al. Establishing the cross-cultural applicability of a harmonized approach to cognitive diagnostics in epilepsy: Initial results of the International Classification of Cognitive Disorders in Epilepsy in a Spanish-speaking sample. Epilepsia. 2023;64:728&#x2013;741. doi: 10.1111/epi.17501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.17501</ArticleId><ArticleId IdType="pmc">PMC10394710</ArticleId><ArticleId IdType="pubmed">36625416</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, et al. Fatigue and cognitive dysfunction are associated with occupational status in post-COVID syndrome. Int. J. Environ. Res. Public Health. 2022;19:13368. doi: 10.3390/ijerph192013368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192013368</ArticleId><ArticleId IdType="pmc">PMC9603617</ArticleId><ArticleId IdType="pubmed">36293950</ArticleId></ArticleIdList></Reference><Reference><Citation>Moccia M, et al. Determinants of early working impairments in multiple sclerosis. Front. Neurol. 2022;13:1062847. doi: 10.3389/fneur.2022.1062847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1062847</ArticleId><ArticleId IdType="pmc">PMC9784221</ArticleId><ArticleId IdType="pubmed">36570442</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver-Mas S, et al. Transcranial direct current stimulation for post-COVID fatigue: A randomized, double-blind, controlled pilot study. Brain Commun. 2023 doi: 10.1093/braincomms/fcad117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad117</ArticleId><ArticleId IdType="pmc">PMC10116605</ArticleId><ArticleId IdType="pubmed">37091591</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana K, et al. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC) Brain Stimul. 2023;16:100&#x2013;107. doi: 10.1016/j.brs.2023.01.1672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.01.1672</ArticleId><ArticleId IdType="pmc">PMC9867562</ArticleId><ArticleId IdType="pubmed">36693536</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front. Immunol. 2021;12:686029. doi: 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O, et al. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J. Psychiatr. Res. 2021;144:129&#x2013;137. doi: 10.1016/j.jpsychires.2021.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Solaro C, Gamberini G, Masuccio FG. Depression in multiple sclerosis: Epidemiology, aetiology, diagnosis and treatment. CNS Drugs. 2018;32:117&#x2013;133. doi: 10.1007/s40263-018-0489-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-018-0489-5</ArticleId><ArticleId IdType="pubmed">29417493</ArticleId></ArticleIdList></Reference><Reference><Citation>Strober L, et al. Symbol digit modalities test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis. Multiple Scler. 2019;25:1781&#x2013;1790. doi: 10.1177/1352458518808204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458518808204</ArticleId><ArticleId IdType="pmc">PMC6826875</ArticleId><ArticleId IdType="pubmed">30334474</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. 2022;18:1047&#x2013;1066. doi: 10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>